C2]-myristic acid; Isotec, Lawrenceville, NJ, USA), methanol (Tedia Co., Inc., Fairfield, OH, USA), n-heptane (Merck KGaA, Darmstadt, Germany), and purified water produced with a Milli-Q system (EMD Millipore, Billerica, MA, USA).
Sample preparation and GC/TOF-MS analysis
Samples were thawed in a 37°C water bath for 15 min. Then, 100 μL of supernatant of centrifuged blood was transferred to an Eppendorf tube and about 20 mg of tissue was weighed. A monophasic mixture of 400 μL of water:methanol (1:4, v:v) containing [ 13 C2]-myristic acid as an internal standard (2.5 μg/mL) was added to the serum sample, which was vortexed for 2 min, cooled at 4°C for 1 h, and then centrifuged at 20,000 rpm for 10 min. Afterward, 100 μL of supernatant was dried in a SpeedVac nitrogen evaporator (Savant Instruments, Inc., Farmingdale, NY, USA) and 30 μL of methoxyamine pyridine solution (10 μg/mL) was added. Then the mixture was vortexed for 3 min and incubated for 16 h at 20°C for methoximation of alcohols.
Afterward, 30 μL of MSTFA with 1% TMCS were added for trimethylsilylation. At last, 30 μL of n-heptane was added to 30 μg/mL of methyl stearate and the solution 
Data processing and statistical analysis
ChromaTOF 2.00 software (LECO Corporation) was used to automatically detect peak values and calculate peak areas. The peak width in automatic peak detection and mass spectrum deconvolution were set at 2 s and peaks of the signal-to-noise ratio less than 20 were rejected. The retention indices of the peaks were calculated based on the ratio of the retention time and those of the C8-C40 alkane series. For identification, the mass spectra and retention indices of themetabolites were searched in the National Institute of Standards and Technology library 2.0 (2012) Wiley 9 (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany), and the discriminant metabolites were further identified with their reference standards respectively. Multivariate data analysis was performed using SIMCA-P 11 software (MKS Umetrics AB, Umeå, Sweden). A data matrix was constructed with the experimental sample names as observational variables and the peak areas normalized to internal standard served as the response variables. Dimension reduction was performed using principal component analysis and partial least squares discriminant analysis (PLS-DA). The maximum differences among groups or samples with several principal components were calculated. A plot of PLS-DA sample scores was used to identify differences among groups. The PLS-DA loading plot was applied to screen the main different endogenous metabolites with variable importance in the projection values of greater than 1. Statistical analysis was performed using the two sample t-test and probability (P) value < 0.05 and < 0.001 were considered statistically and very statistically significant. Variables with striking deviations were further evaluated as potential biomarkers and their structures were confirmed by comparison to authentic reference standards.
